Literature DB >> 29359839

Long-term follow-up of post renal transplantation Epstein-Barr virus-associated smooth muscle tumors: Report of two cases and review of the literature.

Hany M El Hennawy1, Wael Habhab2, Abdulmonem Almutawa3, Sumaih Shinawi3, Abdulrahman Al Ayad1, Ahmed Fahmy1.   

Abstract

Epstein-Barr virus (EBV)-associated smooth muscle tumors (SMTs) following solid organ transplantation are very rare slow growing neoplasms. Most tumors present with non-specific symptoms mainly related to tumor location. Post-transplant EBV-associated small muscle tumors have been reported in various anatomical locations. The tumors have a predilection to unusual sites for SMTs and tend to be multifocal. The histologic appearance of these tumors generally does not predict their clinical behavior. Surgery and reduction in immunosuppression are the main stays of management. We herein report two cases of post renal transplant EBV-associated SMTs with over 6 years of follow-up. A 33-year-old male patient presented with hepatic lesions and a 49-year-old female patient presented with multiple mesenteric and gluteal lesions. The tumors were diagnosed 6 and 10 years after renal transplantation, respectively. Surgical resection and reduction/discontinuation of immunosuppression were successful in delaying progression of the disease; however, in both cases, the allografts failed during the course of management.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  neoplasms; pathology; transcription factors; transplantation; virus

Mesh:

Year:  2018        PMID: 29359839     DOI: 10.1111/tid.12841

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  2 in total

1.  EBV-associated myoid tumor with lipoblast-like cells in a patient with normal immunity.

Authors:  Ruohao Wu; Wenting Tang; Danxia Tang; Yu Li; Lijuan Bian; Yang Li
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

2.  Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report.

Authors:  Bjoern-Thore Hansen; Petra Bacher; Britta Eiz-Vesper; Steffen M Heckl; Wolfram Klapper; Karoline Koch; Britta Maecker-Kolhoff; Claudia D Baldus; Lars Fransecky
Journal:  Front Immunol       Date:  2021-12-03       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.